CADDRA is a Canadian non-profit member association for medical and health care professionals, along with researchers, who assess, treat and/or study ADHD. | |
Research Day and Conference Keynote Speaker | |
Brooke S. G. Molina, PhD, is Professor of Psychiatry, Psychology, and Pediatrics at the University of Pittsburgh, Director of the Youth and Family Research Program, and Director of Clinical Research at the ADHD Across the Lifespan Clinic. She is also a licensed clinical psychologist. Dr. Molina researches the etiology, course, and treatment of alcohol and drug abuse and Attention-Deficit/Hyperactivity Disorder (ADHD). Her research program, federally funded for over two decades, includes longitudinal studies of children and adolescents followed into adulthood, neuroimaging studies of brain structure and function in relation to long-term symptom course, treatment studies of behavioral and pharmacologic approaches, and development of primary care-based strategies for management of ADHD.
| |
KBHN/CADDRA Trainee Researcher Awards | |
We are excited to announce that Kids Brain Health Network (KBHN), for the seventh consecutive year, is generously providing $5,000 towards awards for selected oral and poster presentations by student/trainee presenters based on merit. | |
Plan your downtime using this special CADDRA delegate microsite provided by Tourism Winnipeg. | |
Reserve your Accommodation!
CADDRA 2024 will be hosted at the convenient downtown location of the Fairmont Winnipeg in Winnipeg, Manitoba.
A limited block of rooms has been set aside at a special reduced rate for CADDRA 2024 attendees.
Reserve your room now!
| |
We are delighted to announce that CADDRA 2025 will take place in Vancouver, British Columbia from October 17-19. Mark your calendar for our 12th Annual ADHD Research Day and 21st Annual Conference, taking place at the Sheraton Vancouver Wall Centre Hotel in downtown Vancouver. | |
|
Current ADHD Research
Please note: These are links to research abstracts. Some are available without cost and others require a subscription.
| |
CADDRA ADHD and Substance Use Program | |
As the CADDRA ADHD and Substance Use Program (CASUP) continues online development, we would like to highlight some key information that will be discussed in greater detail in the course. | |
|
Substance use disorders (SUDs) are one of the conditions most commonly comorbid with ADHD, with approximately 1 in 4 people with ADHD also having a SUD. 1, 2
Individuals whose ADHD symptoms are untreated or undertreated may use substances as a form of self-medication, emphasizing the importance of thorough assessment, timely diagnosis, and adequate treatment. 2, 3
At worst, ADHD medications have no impact on SU/SUDs. At best, ADHD medication can help reduce the likelihood of early SU and later development of SUDs when children with ADHD are treated early and consistently and can improve SUD treatment outcomes. 4-9
| |
|
The course will launch in late 2024 on ADHDLearn. Click on the "Get Early Notification" button to receive advance email notification when the course launches. | |
|
|
ADHD added to Manitoba Payments List
ADHD is now included in an expanded list of mental health diagnosis eligible for panel payments under Manitoba’s Family Medicine Plus (FM+). Panel payments are a new stream of non-volume-based funding based on the age and complexity of each patient. They replace Comprehensive Care Management (CCM) tarrifs. Further information.
| |
|
APSARD Education Committee
The APSARD Education Committee is presenting a new 4-module CME activity: Treating ADHD with Non-Stimulant Medications.
Access the program here on adhdinadults.com.
| |
|
mindyourmind
mindyourmind.ca has undergone a website makeover!
The Canadian organization fosters connections between young people and communities empowering them to co-create solutions to enhance youth well being such as:
| |
|
|
Are You Professionally Involved with ADHD?
Discover the benefits of becoming a member of CADDRA.
FIND OUT MORE
| | | | | | |
